Health LLMs Predict Disease 20 Years Out

The Delphi-2M model was trained on the anonymized health records of approximately 400,000 participants from the UK Biobank and validated on 1.9 million individuals from Denmark's national patient registry. This generative AI uses a transformer architecture, similar to large language models, to analyze a person's medical history as a sequence of health events, including past diagnoses, age, sex, and certain lifestyle factors. While it shows strong predictive capabilities for diseases with clear progression patterns like cardiovascular disease and diabetes, its accuracy is lower for conditions influenced by random events, such as infections. For consumer health startups, integrating with wearable APIs is crucial for personalization and engagement, with unified APIs for Apple HealthKit, Fitbit, Oura, and Whoop reducing development time from months to weeks. Successful apps like Ada, an AI-powered symptom checker with over 10 million users, leverage machine learning to provide personalized health assessments. However, building user trust is paramount; this involves transparent privacy policies, clear communication about data usage, and demonstrating the involvement of medical professionals. Navigating health data privacy is a significant hurdle, as consumer-generated data from wellness apps often falls outside of HIPAA's protections. States like California, with its Consumer Privacy Rights Act (CPRA), and Washington, with the My Health My Data Act, have enacted stricter laws that require explicit consumer consent for data collection and sharing. These state-level regulations create a complex compliance landscape for developers. From a founder's perspective, the digital health sector is attracting significant venture capital, with early-stage funds like Rock Health, Bold Capital Partners, and Continuum Health Ventures actively investing. The journey from a technical founder to a CEO requires a shift in focus to include strategic partnerships, fundraising, and building a strong company culture. Many successful solo founders emphasize the importance of leveraging their technical background to inform product development while actively learning business and leadership skills. The longevity and biohacking community offers a glimpse into the future of consumer health, with startups like Altos Labs, backed by Jeff Bezos, and BioAge Labs focusing on cellular rejuvenation and therapies that mimic the benefits of exercise. This sector has seen a surge in investment, with longevity-focused startups raising $8.5 billion in venture capital in 2024. The movement is shifting from just extending lifespan to enhancing "healthspan," the years of healthy, active life.